Rentokil Initial (RKLIF) EBITDA (2021 - 2025)

Rentokil Initial (RKLIF) has 5 years of EBITDA data on file, last reported at $510.0 million in Q4 2025.

• EBITDA for Q4 2025 came in at $510.0 million, down 27.86% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.7 billion (down 48.59% YoY), and the FY2025 annual result was $475.0 million, down 65.2% from the prior year.
• EBITDA grew to $510.0 million in Q4 2025 per RKLIF's latest filing, from -$230.0 million in the prior quarter.
• Over five years, EBITDA peaked at $1.0 billion in Q4 2022 and troughed at -$230.0 million in Q3 2025.
• A 5-year average of $608.8 million and a median of $727.1 million in 2023 frame the typical range for EBITDA.
• The sharpest annual moves came in 2022 and 2025: EBITDA rose 10.57% in 2022, then fell 27.86% in 2025.
• A 5-year view of EBITDA shows it stood at $911.3 million in 2021, then grew by 10.57% to $1.0 billion in 2022, then fell by 25.84% to $747.2 million in 2023, then slipped by 5.38% to $707.0 million in 2024, then decreased by 27.86% to $510.0 million in 2025.
• Business Quant data shows RKLIF's EBITDA at $510.0 million in Q4 2025, -$230.0 million in Q3 2025, and $707.0 million in Q4 2024.